Two rulings on the abortion drug mifepristone raise questions about the FDA’s authority. NPR’s Michel Martin talks with medical ethics expert Holly Fernandez Lynch of the University of Pennsylvania.
© 99.7 KVUT & KVUT.org • a community service of the College of Arts and Sciences at The University of Texas at Tyler • All Rights Reserved • Privacy Policy